Alphatec Holdings

In a recent report from Jefferies, Alphatec Holdings' (NASDAQ: ATEC) 1Q revenue exceeded forecasts and adjusted earnings were in line with expectations resulting in Jefferies maintaining a buy rating on ATEC and believing risks in the outlook will continue to diminish. In the report, Jefferies...

Alphatec Holdings (NASDAQ: ATEC) has been granted FDA approval for Solus, an anterior interbody fusion device produced by the company, says Jefferies. In its report, Jefferies writes, “The approval of Solus gives ATEC a unique entrant into the $350mn US market for standalone ALIF devices. It is...